Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Celestia S. Higano, MD
University of Washington
Study Chair - Laurence H. Klotz, MD
Toronto Sunnybrook Regional Cancer Centre
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Centre
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Bcca - Cancer Centre for the Southern Interior
Kelowna, British Columbia, Canada
- Bcca - Fraser Valley Cancer Centre
Surrey, British Columbia, Canada
- Bcca - Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- Clinical Research Unit at Vancouver Coastal
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- the Vitalite Health Network - Dr. Leon Richard
Moncton, New Brunswick, Canada
- Atlantic Health Sciences Corporation
Saint John, New Brunswick, Canada
- Dr. H. Bliss Murphy Cancer Centre
St. John's, Newfoundland and Labrador, Canada
- Qeii Health Sciences Center
Halifax, Nova Scotia, Canada
- William Osler Health Centre, Brampton Memorial
Brampton, Ontario, Canada
- Northeast Cancer Center Health Sciences
Greater Sudbury, Ontario, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Cancer Centre of Southeastern Ontario at Kingston
Kingston, Ontario, Canada
- London Regional Cancer Program
London, Ontario, Canada
- Credit Valley Hospital
Mississauga, Ontario, Canada
- Ottawa Health Research Institute - General Division
Ottawa, Ontario, Canada
- Niagara Health System
St. Catharines, Ontario, Canada
- Thunder Bay Regional Health Science Centre
Thunder Bay, Ontario, Canada
- Odette Cancer Centre
Toronto, Ontario, Canada
- Univ. Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- Windsor Regional Cancer Centre
Windsor, Ontario, Canada
- Chum - Hopital Notre-Dame
Montreal, Quebec, Canada
- Mcgill University - Dept. Oncology
Montreal, Quebec, Canada
- Chuq-Pavillon Hotel-Dieu de Quebec
Québec, Quebec, Canada
- Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Jan 1999
- Primary completion
- 4 Oct 2010
- Completion
- 10 Jan 2013
- Last update posted
- 23 Jun 2021
- Registered enrollment
- 1,386
- Registry id
- NCT00003653
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.